Literature DB >> 7666513

Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport.

R Thäle1, U Szepan, H Hengel, G Geginat, P Lucin, U H Koszinowski.   

Abstract

Mouse cytomegalovirus (MCMV) functions expressed at the beginning of the early phase of the viral replication cycle interfere with the major histocompatibility complex (MHC) class I-restricted pathway of antigen presentation (M. J. Reddehase, M. R. Fibi, G. M. Keil, and U. H. Koszinowski, J. Virol. 60:1125-1129, 1986; M. Del Val, K. Münch, M. J. Reddehase, and U. H. Koszinowski, Cell 58:305-315, 1989). Nascent MHC class I heavy chains associate with beta 2-microglobulin and peptide, but the assembled trimolecular complex is retained in the endoplasmatic reticulum/cis-Golgi compartment (M. Del Val, H. Hengel, H. Häcker, U. Hartlaub, T. Ruppert, P. Lucin, and U. H. Koszinowski, J. Exp. Med. 176:729-738, 1992). To locate the responsible genomic region, the cytoplasmic retention of MHC class I molecules after injection of MCMV DNA was tested. The function was mapped to the HindIII E fragment. A recombinant MCMV deletion mutant delta MS94.5 lacking 15.8 kb in HindIII-E was constructed. Restoration of MHC class I molecule maturation and recognition of antigenic peptides by cytolytic T lymphocytes during the first hours of the early phase in mutant virus-infected cells proved the correct location to a 6.8-kb region in the HindIII E fragment. At later stages of the early phase, membrane-resident MHC class I molecules and cytolytic T lymphocyte recognition disappeared in delta MS94.5 mutant virus-infected cells. These results demonstrate that more than one early-gene function of MCMV affects the MHC class I pathway of antigen presentation. The redundant MHC class I-reactive functions target the transport of MHC class I molecules at different steps.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7666513      PMCID: PMC189506     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Extensive peptide ligand exchange by surface class I major histocompatibility complex molecules independent of exogenous beta 2-microglobulin.

Authors:  J D Smith; W R Lie; J Gorka; N B Myers; T H Hansen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

2.  Beta-COP is essential for biosynthetic membrane transport from the endoplasmic reticulum to the Golgi complex in vivo.

Authors:  R Pepperkok; J Scheel; H Horstmann; H P Hauri; G Griffiths; T E Kreis
Journal:  Cell       Date:  1993-07-16       Impact factor: 41.582

3.  Characterization of a strain of murine cytomegalovirus which fails to grow in the salivary glands of mice.

Authors:  J M Boname; J K Chantler
Journal:  J Gen Virol       Date:  1992-08       Impact factor: 3.891

4.  Herpes simplex virus turns off the TAP to evade host immunity.

Authors:  A Hill; P Jugovic; I York; G Russ; J Bennink; J Yewdell; H Ploegh; D Johnson
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

5.  Down-regulation of the major histocompatibility complex class I enhancer in adenovirus type 12-transformed cells is accompanied by an increase in factor binding.

Authors:  R Ge; A Kralli; R Weinmann; R P Ricciardi
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Molecular cloning and physical mapping of murine cytomegalovirus DNA.

Authors:  A Ebeling; G M Keil; E Knust; U H Koszinowski
Journal:  J Virol       Date:  1983-09       Impact factor: 5.103

7.  Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain).

Authors:  J A Mercer; J R Marks; D H Spector
Journal:  Virology       Date:  1983-08       Impact factor: 3.616

8.  Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells.

Authors:  P I Schrier; R Bernards; R T Vaessen; A Houweling; A J van der Eb
Journal:  Nature       Date:  1983 Oct 27-Nov 2       Impact factor: 49.962

9.  Redistribution and differential extraction of soluble proteins in permeabilized cultured cells. Implications for immunofluorescence microscopy.

Authors:  M A Melan; G Sluder
Journal:  J Cell Sci       Date:  1992-04       Impact factor: 5.285

10.  Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment.

Authors:  M del Val; H Hengel; H Häcker; U Hartlaub; T Ruppert; P Lucin; U H Koszinowski
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

View more
  33 in total

1.  A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Authors:  U Reusch; W Muranyi; P Lucin; H G Burgert; H Hengel; U H Koszinowski
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication.

Authors:  Anja Bubeck; Markus Wagner; Zsolt Ruzsics; Mark Lötzerich; Margot Iglesias; Ila R Singh; Ulrich H Koszinowski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Cytomegalovirus encodes a positive regulator of antigen presentation.

Authors:  Rafaela Holtappels; Dorothea Gillert-Marien; Doris Thomas; Jürgen Podlech; Petra Deegen; Sylvia Herter; Silke A Oehrlein-Karpi; Dennis Strand; Markus Wagner; Matthias J Reddehase
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

4.  A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.

Authors:  M F Kleijnen; J B Huppa; P Lucin; S Mukherjee; H Farrell; A E Campbell; U H Koszinowski; A B Hill; H L Ploegh
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

5.  The efficacy of antigen processing is critical for protection against cytomegalovirus disease in the presence of viral immune evasion proteins.

Authors:  Rafaela Holtappels; Doris Thomas; Matthias J Reddehase
Journal:  J Virol       Date:  2009-06-24       Impact factor: 5.103

6.  Control of murine cytomegalovirus in the lungs: relative but not absolute immunodominance of the immediate-early 1 nonapeptide during the antiviral cytolytic T-lymphocyte response in pulmonary infiltrates.

Authors:  R Holtappels; J Podlech; G Geginat; H P Steffens; D Thomas; M J Reddehase
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome.

Authors:  M Messerle; I Crnkovic; W Hammerschmidt; H Ziegler; U H Koszinowski
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  Preemptive CD8 T-cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genomes, and reduces the risk of virus recurrence.

Authors:  H P Steffens; S Kurz; R Holtappels; M J Reddehase
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

Review 9.  Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation.

Authors:  Y Yang; P Sempé; P A Peterson
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 10.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.